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■ Abstract
We describe 5 cases of immediate-type reactions to systemic corticosteroids observed during the last 2 decades in boys aged 2, 4, 8, 9, 
and 10 years. Symptoms ranged from generalized urticaria and angioedema to anaphylactic shock immediately after administration. Oral 
betamethasone was implicated in 2 cases, oral prednisolone in 2 cases, and intravenous prednisolone in 1 case. The parents of patient 5 
refused the skin tests. The remaining patients underwent skin prick tests with the following undiluted corticosteroids: parenteral prednisolone, 
oral prednisolone, parenteral methylprednisolone, parenteral dexamethasone, parenteral hydrocortisone, and oral betamethasone. If the 
results were negative, intradermal tests were performed with the same drugs at increasing concentrations. Skin test results were positive 
for all suspect corticosteroids, thus indicating an immunoglobulin E–mediated mechanism. Two patients had positive skin test results to 
other corticosteroids, suggesting cross-reactivity. An oral challenge test was performed with defl azacort in 4 cases and with betamethasone 
in 1 case; the results were negative. 
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■ Resumen
Se describen 5 casos de reacciones inmediatas a corticoesteroides sistémicos observados durante las dos últimas décadas en niños de 2, 
4, 8, 9 y 10 años de edad. Los síntomas incluyeron desde urticaria generalizada y angioedema hasta choque anafi láctico inmediatamente 
después de la administración. La betametasona oral estuvo implicada en 2 casos, la prednisolona oral en otros 2 casos y la prednisolona 
intravenosa en 1 caso. El quinto paciente rechazó someterse a pruebas cutáneas. El resto de pacientes se sometieron a pruebas de 
punción cutánea con los corticoesteroides no diluidos siguientes: prednisolona parenteral, prednisolona oral, metilprednisolona parenteral, 
dexametasona parenteral, hidrocortisona parenteral y betametasona oral. Si los resultados eran negativos, debían realizarse pruebas 
intradérmicas con los mismos fármacos a concentraciones crecientes. Los resultados de las pruebas cutáneas fueron positivos para todos 
los corticoesteroides sospechosos, lo que indica un mecanismo mediado por la inmunoglobulina E. Dos pacientes obtuvieron resultados 
positivos en las pruebas cutáneas para otros corticoesteroides, lo que indica reactividad cruzada. Se realizó una prueba de provocación 
oral con defl azacort en 4 casos y con betametasona en 1 caso; los resultados fueron negativos. 
Palabras clave: Corticoesteroides sistémicos. Hipersensibilidad. Reacciones inmediatas. Niños. Pruebas cutáneas.
Introduction
Corticosteroids have been used since the late 1940s for 
their anti-infl ammatory and immunomodulatory effects [1]. 
They are still used today in patients of all ages with a range 
of diseases (allergic, cutaneous, respiratory, rheumatologic, 
renal) and even in transplant recipients. This broad spectrum 
means that several specialties use these agents on a daily 
basis in settings ranging from the private offi ce to the 
emergency room. Hypersensitivity most commonly presents 
with topical corticosteroids, and the incidence of delayed-
type hypersensitivity is between 0.2% and 5% [2-4]. 
Immediate-type, anaphylactic reactions to systemic 
corticosteroids are very uncommon, but can prove fatal. 
Little is known regarding their incidence, although some 
authors have estimated it to be 0.1% to 0.3% [4-6]. Most 
of the reports describe individual cases or small series [7,8] 
and mainly involve adults. The number of cases in pediatric 
patients is also small [9-11], despite widespread use of 
corticosteroids in this population. We report the only 5 
cases of immediate-type hypersensitivity to systemic 
corticosteroids in children observed and studied by the 
authors in the last 2 decades.
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Case Description
Case 1
A 9-year-old boy with no known history of allergic disease 
and no previous prescription of corticosteroids received 
prednisolone succinate intravenously for a large local reaction 
after an insect bite. After 5 to 10 minutes he developed urticaria, 
rhinoconjunctivitis, dyspnea, and hypotension, which promptly 
resolved with intramuscular adrenaline and antihistamines.
Case 2
A 10-year-old boy with a history of allergic rhinitis and 
asthma experienced 2 separate yet similar episodes of acute 
urticaria, angioedema, and vomiting immediately after taking 
oral prednisolone prescribed for an asthma exacerbation. These 
episodes were self-limiting and did not require treatment.
Table 1. Characteristics of Study Subjects and Healthy Volunteersa
  Patient Culprit Corticosteroid SPT IDT Oral Challenge Test
 1 Intravenous prednisolone Positive for PSG, Negative Negative for
  succinate prednisolone succinate,  betamethasone
   and methylprednisolone,
   Negative for 
   dexamethasone, 
   hydrocortisone succinate,
   and betamethasone
 2 Oral prednisolone Positive for PSG. Positive for prednisolone Negative for defl azacort
   Negative for prednisolone succinate (1:100). 
   succinate,  Negative for
   methylprednisolone methylprednisolone
   succinate, dexamethasone, succinate, dexamethasone,
   hydrocortisone succinate, hydrocortisone succinate,
   and betamethasone Testing for PSG was not
    performed
 3 Oral betamethasone Negative Positive for betamethasone Negative for defl azacort
    (1/100). 
    Negative for PSG,
    prednisolone succinate,
    methylprednisolone
    succinate, dexamethasone,
    hydrocortisone succinate,
    and betamethasone
 4 Oral betamethasone Negative Positive for betamethasone Negative for defl azacort
    (1/10).
    Negative for PSG,
    prednisolone succinate,
    methylprednisolone
    succinate, dexamethasone,
    hydrocortisone succinate,
    and betamethasone
 5 Oral prednisolone ND ND Negative for defl azacort  
Abbreviations: IDT, intradermal test; ND, not done; PSG, prednisolone stearoyl glycolate; SPT, skin prick test. 
Case 3
An 8-year-old boy with a history of allergic rhinitis and 
asthma complained of oral angioedema and facial urticaria that 
rapidly generalized and was accompanied by sudoresis and a 
feeling of impending doom 5-10 minutes after taking 70 drops 
of betamethasone prescribed for an asthma exacerbation. He 
was medicated in the emergency room with antihistamines and 
an unknown corticosteroid. His symptoms resolved.
Case 4
A 4-year-old boy who had received oral betamethasone 
for an asthma exacerbation experienced immediate-type 
generalized urticaria and angioedema and lost consciousness 
5 minutes after ingestion. His symptoms resolved after 
administration of adrenaline and an unknown corticosteroid in 
the emergency room. The patient had a history of anaphylaxis 
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to snail. The parents reported another 2 self-limiting episodes 
of immediate-type facial urticaria and angioedema after the 
ingestion of the same drug 3 months earlier.
Case 5
A 2-year-old nonatopic boy experienced generalized 
urticaria and angioedema less than 15 minutes after taking the 
third dose of oral prednisolone for nephrotic syndrome. His 
symptoms resolved with systemic antihistamines. After the 
second dose, 8 hours earlier, the parents referred mild facial 
urticaria that resolved spontaneously in 2 hours.
Informed consent was obtained from the parents of patients 
1 to 4 to perform skin prick tests (SPT), intradermal tests 
(IDT), and oral challenge tests with alternative corticosteroids. 
The parents of patient 5 refused the skin tests, but agreed 
to the oral challenge test. SPTs were performed with the 
following undiluted corticosteroids: intravenous prednisolone 
sodium succinate, 10 mg/mL; oral prednisolone stearoyl 
glycolate,  20 mg/mL; intravenous methylprednisolone sodium 
succinate, 40 mg/mL; intravenous dexamethasone sodium 
phosphate, 5 mg/mL; intravenous hydrocortisone sodium 
succinate, 50 mg/mL; and oral betamethasone, 0.5 mg/mL. 
IDTs with the same corticosteroids were performed in 10-fold 
increasing concentrations (1:1000 to 1:10) only if the SPTs 
were negative. Skin tests to defl azacort were not performed 
because hypersensitivity reactions to this drug have never been 
reported, and, to our knowledge no other authors perform them. 
We applied the positivity criteria suggested in the European 
Academy of Allergy and Clinical Immunology position paper 
on skin tests in the diagnosis of drug hypersensitivity [12]. 
These results are summarized in the Table. The same SPTs 
and IDTs were performed in 10 adult atopic volunteers and 
were all negative.
All patients had a positive skin test result to at least 1 
corticosteroid. Single-blind placebo-controlled oral challenge 
with an alternative systemic corticosteroid was performed in 
all cases: betamethasone in patient 1 and defl azacort in the 
remainder. Defl azacort was not used in patient 1 because it 
was not commercially available when the child was studied. 
The methodology used for the challenge tests was as follows: 
the daily dose of corticosteroid was determined according to 
current weight and progressively administered at 20-minute 
intervals (10%, 20%, 30%, and fi nally 40% of the total daily 
dose). The challenge test results were invariably negative.
Discussion
The mechanism of action of this type of immediate-type 
reaction to systemic corticosteroids has been much debated. 
Some authors have suggested an immunoglobulin (Ig) 
E–mediated reaction [13]. In our case, skin test results with 
the suspect drug were positive in all patients tested, strongly 
indicating an IgE-mediated reaction. An irritant effect at higher 
corticosteroid concentrations can be virtually ruled out, as 
none of the atopic controls had positive skin test results. All 
patients had previously been exposed to one or more systemic 
corticosteroids, except patient 1. It is therefore difficult 
to explain the presumably IgE-mediated reaction, although 
neonatal administration or administration during the fi rst years 
of life cannot be totally ruled out, as this was solely based on 
the parents’ testimony. Patients 1 and 2 also had positive skin 
test results to at least one other corticosteroid, thus raising the 
possibility of cross-reactivity, which is consistent with the results 
of some authors [7,13] and contradicts those of others [8]. In 
this regard, cross-reactivity has mainly been reported between 
hydrocortisone, prednisolone and methylprednisolone [7,13]. 
These 3 corticosteroids have also been the most frequently 
associated with immediate-type reactions [7-9]. In our 
population, prednisolone was implicated in 3 cases and 
betamethasone in 2, although the latter has very rarely been 
linked with this type of hypersensitivity. Prescription habits 
can account at least partially for these differences. In Portugal, 
prednisolone, betamethasone, and deflazacort are by far 
the most commonly prescribed systemic corticosteroids for 
children.
Defl azacort, dexamethasone, and betamethasone are usually 
considered safe systemic alternatives in immediate-type allergy 
[7,8,10]. This observation is consistent with our results, as 4 
patients tolerated defl azacort and 1 tolerated betamethasone. 
The safety profi le of these agents is particularly relevant, as 3 
of our patients were asthmatic and could thus have required 
systemic corticosteroids as rescue medication. 
The main limitation of our study is that we did not perform 
challenge tests with the suspect drug. However, the high risk 
involved, the patients’ clinical histories, and the positive skin 
test results render such a procedure ethically questionable, 
especially in children.
To our knowledge, this is the largest published series of 
pediatric patients with well-characterized immediate-type 
reactions to systemic corticosteroids. Immediate-type reaction 
to corticosteroids is probably underdiagnosed, because 
symptoms can mimic a worsening of the underlying disease. 
Emergency room staff in particular must be aware of this type 
of hypersensitivity reaction and take it into consideration in the 
differential diagnosis of a patient who has received a systemic 
corticosteroid.
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